Gilteritinib, CAS [[1254053-43-4]]

Produktübersicht

• Artikelname: Gilteritinib, CAS [[1254053-43-4]]
• Artikelnummer: TGM-T4409
• Hersteller Artikelnummer: T4409
• Alternativnummer: TGM-T4409-1G,TGM-T4409-1MG,TGM-T4409-2MG,TGM-T4409-5MG,TGM-T4409-10MG,TGM-T4409-25MG,TGM-T4409-50MG,TGM-T4409-100MG,TGM-T4409-500MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: ASP2215

Produktbeschreibung

Gilteritinib (ASP2215) is a potent inhibitor of FMS-related tyrosine kinase 3 (FLT3) and AXL tyrosine kinase receptors (IC50 = 0.29 nM and <1 nM, respectively). In preclinical studies, gilteritinib demonstrated strong antileukemic and antitumor effects. Gilteritinib is currently in several Phase 3 clinical trials for acute myeloid leukemia.

Produkteigenschaften

• Molekulargewicht: 552.71
• Reinheit: 97.75%
• CAS Nummer: [1254053-43-4]
• Formel: C29H44N8O3
• Target-Kategorie: FLT|||TAM Receptor|||c-Kit

Bilder

T4409